文献速递血管炎

颞动脉与腋动脉超声的晕征计数能否预测巨细胞动脉炎复发时间

Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis?
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

本研究为单中心回顾性研究,纳入72例确诊巨细胞动脉炎患者,评估诊断时颞动脉与腋动脉超声的晕征计数是否预测复发时间。中位随访20.9个月,37例(51.4%)复发;单变量分析中较高晕征计数与较短复发时间相关(每个晕征风险比1.15,95%CI 1.02-1.30,P=0.028),但排除10例晕征计数为零者后显著性消失。腋动脉受累未预测复发。

要点

  • 晕征计数较高与较短复发时间相关(每个晕征风险比1.15,95%CI 1.02-1.30,P=0.028),但排除晕征计数为零的患者后显著性消失。
  • 37/72例(51.4%)复发,复发时泼尼松龙剂量中位9 mg(范围0-40 mg)。
  • 腋动脉(大血管)受累未预测复发。

核心结论

  • 在真实世界环境中,复发发生于广泛的糖皮质激素剂量范围,且腋动脉受累未预测复发。
  • 诊断时晕征计数较高的巨细胞动脉炎患者显著更可能复发,但排除晕征计数为零者后显著性消失。
  • 晕征计数在常规诊疗中可行,可能值得纳入未来预后评分。
  • 需进一步研究以确定超声阴性的确诊巨细胞动脉炎患者是否代表疾病谱中性质不同的亚表型。

研究设计与样本

  • 单中心回顾性研究,纳入72例确诊巨细胞动脉炎患者,中位随访20.9个月。
  • 晕征计数定义为诊断时颞动脉与腋动脉超声上显示不可压缩晕征的血管数量,通过回顾性审阅超声报告和图像确定。
  • 复发定义为巨细胞动脉炎疾病活动度增加需要升级治疗。
  • 采用Cox比例风险回归识别复发时间的预测因素。

主要发现

  • 72例中37例(51.4%)在随访期间复发,复发时泼尼松龙剂量中位9 mg(范围0-40 mg)。
  • 大血管(腋动脉)受累未预测复发。
  • 单变量分析中,较高晕征计数与较短复发时间相关(每个晕征风险比1.15,95%CI 1.02-1.30,P=0.028)。
  • 排除10例晕征计数为零的巨细胞动脉炎患者后,该关联失去统计学显著性。

临床怎么用

  • 晕征计数在常规诊疗中可行,可能值得纳入未来预后评分(作者认为)。

局限性

  • 单中心回顾性研究。
  • 排除10例晕征计数为零的患者后,晕征计数与复发时间的关联失去统计学显著性。
  • 需进一步研究以确定超声阴性的确诊巨细胞动脉炎患者是否代表疾病谱中性质不同的亚表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine whether the halo count (HC) on temporal and axillary artery US (TAUS) predicts time to relapse in giant cell arteritis (GCA). METHODS: We conducted a single-centre retrospective study of GCA patients. HC, the number of vessels with non-compressible halo on the TAUS at diagnosis, was determined by retrospective review of the US report and images. Relapse was defined as increase in GCA disease activity requiring treatment escalation. Cox proportional hazard regression was used to identify predictors of time to relapse. RESULTS: A total of 72 patients with confirmed GCA were followed up for a median of 20.9 months. Thirty-seven of 72 (51.4%) relapsed during follow-up, at a median prednisolone dose of 9 mg (range 0-40 mg). Large-vessel (axillary artery) involvement did not predict relapse. On univariable analysis, a higher HC was associated with shorter time to relapse (per-halo hazard ratio 1.15, 95% CI 1.02, 1.30; P = 0.028). However, statistical significance was lost when the 10 GCA patients with an HC of zero were excluded from analysis. CONCLUSION: In this real-world setting, relapse occurred at a wide range of glucocorticoid doses and was not predicted by axillary artery involvement. GCA patients with a higher HC at diagnosis were significantly more likely to relapse, but significance was lost on excluding those with HC of zero. HC is feasible in routine care and may be worth incorporating into future prognostic scores. Further research is required to determine whether confirmed GCA patients with negative TAUS represent a qualitatively different subphenotype within the GCA disease spectrum.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Esperança Almeida D, Smith K, Sarker BA, et al. Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis? Rheumatology (Oxford). 2023. PMID: 37137277. doi:10.1093/rheumatology/kead179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。